Position in ENOV
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,687,685
-$243,901 QoQ
Shares Held
74,184
+2.3% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENOV Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Amundi holds $3,738,807,958 across 34 Medical Devices names. ENOV ranks #20 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
14,122,913 | $886,212,788 | |
| 2 | ABT |
Abbott Laboratories
|
7,406,961 | $760,472,679 | |
| 3 | MDT |
Medtronic plc
|
6,070,236 | $525,985,944 | |
| 4 | DXCM |
Dexcom Inc
|
6,332,561 | $397,684,830 | |
| 5 | SYK |
Stryker Corp
|
1,053,906 | $346,302,970 | |
| 6 | EW |
Edwards Lifesciences Corp
|
2,670,209 | $213,830,334 | |
| 7 | STE |
STERIS plc
|
771,092 | $170,511,571 | |
| 8 | PEN |
Penumbra Inc
|
345,758 | $113,536,553 |
All Filings in ENOV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,687,685 | 74,184 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,931,586 | 72,507 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $297,392 | 9,802 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $307,390 | 9,802 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,528 | 40 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,755 | 40 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $885,946 | 13,817 | Shares | Defined | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||